Rapeeporn Tiamjan

Rapeeporn Tiamjan

Auto-generated profile, based on publicly available information

Rapeeporn Tiamjan

Department of Public Health Faculty of Science and Technology Chiang Mai Rajabhat University Chiang Mai Thailand

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2022 in Public Health Challenges
Verified
Journal Article
Open access
MJMANATEE JITANAN
MANATEE JITANAN
TCTharisara Chirasatienpon
Tharisara Chirasatienpon
RTRapeeporn Tiamjan
Rapeeporn Tiamjan
KAKwanjai Amnatsatsue
Kwanjai Amnatsatsue
RNRachanon Nguanjairak
Rachanon Nguanjairak
MKM.B.N. Kouwenhoven
M.B.N. Kouwenhoven
The COVID‐19 outbreak has had a great impact on the social, economic, and health systems of Thailand. A variety of measures to curb the spread of the disease were implemented since the beginning of the pandemic, including a strict national lockdown protocol. The Thai government aimed to achieve herd immunity through an efficient vaccination programme. Initially, vaccine supply shortage and a lack of vaccine options plagued the health system, but this has since been improved. Continuous monitoring of the situation through research is being carried out to assess the level of immunity among the population whereby the current general recommendation is presently a fourth booster dose for adults. Hurdles towards achieving herd immunity remain. One such issue is the low level of vaccine literacy among those that are unvaccinated or inadequately vaccinated. Another obstacle is the sizeable rate of hesitancy towards getting booster doses. Achieving herd immunity in the Thai population would require multilateral cooperation, improved health promotion to target population groups, such as older adults, and a developed distribution system for those with limited access, such as those in the rural areas.

1 February 2023 in Public Health Challenges
Verified
Journal Article
Open access
MJMANATEE JITANAN
MANATEE JITANAN
RTRapeeporn Tiamjan
Rapeeporn Tiamjan
SCSarinporn Chaivisit
Sarinporn Chaivisit
PLPornchan Lojanasupareuk
Pornchan Lojanasupareuk
MBManas Ranjan Behera
Manas Ranjan Behera
AMAdriana Viola Miranda
Adriana Viola Miranda
COVID‐19 vaccine wastage is an emerging issue globally. In Thailand, which has declared COVID‐19 to be an endemic disease, the risk of vaccine wastage lingers despite the remaining vaccine inequity. Although the country does not publicly report its vaccine wastage rate, a wastage incident has been reported. With the remaining secured vaccine doses that have yet to be delivered and Thailand's pandemic‐to‐endemic transition, Thailand should strategize to avoid vaccine wastage. This commentary highlights several factors that can potentially lead to vaccine wastage in Thailand: cold chain logistics issues, vaccine hesitancy, and unequal vaccine accessibility. The Thai government should continue its efforts in mitigating these issues to maximize its vaccination program.